|
|
||||||||
School of Physiology and Pharmacology, University of New South Wales, Sydney, Australia.
1. Angiotensin II (AII) was infused I.V. into seven chronically catheterized fetal sheep (gestational age, 120-136 days). The effects of short-term infusions of 6 and 12 micrograms kg-1 h-1 for 1.5 h were compared with the effects of infusing 6 micrograms kg-1 h-1 for 3 or 5 days (long-term infusion). AII produced an immediate rise in fetal arterial blood pressure (P < 0.025). When infused for 3 or 5 days, 6 micrograms kg-1 h-1 AII caused a greater increase in arterial blood pressure (P < 0.05). 2. Infusions of 6 micrograms kg-1 h-1 AII for 1.5 h had no effect on fetal placental blood flow or on flow to the fetal membranes, but after AII infusion for 3 or 5 days both flows were reduced (P < 0.01 and P < 0.005, respectively). Fetal blood gas status and pH were maintained. The only change in fetal renal function observed with short-term infusions of AII was a rise in sodium excretion when 12 micrograms kg-1 h-1 AII was given (P < 0.05). Infusion of 6 micrograms kg-1 h-1 for 3 or 5 days also caused a rise in sodium excretion (P < 0.025) because total and proximal fractional sodium reabsorptions were depressed (P < 0.01). Infusions of AII had no effects on the volume of lung liquid produced or on its composition. 3. Administration of indomethacin to the ewe (10 mg kg-1) and to the fetus (12 mg kg-1), during the infusion of AII, caused a rise in maternal arterial pressure (P < 0.01) but no change in fetal arterial pressure. 4. After indomethacin, umbilicoplacental blood flow rose (P < 0.05), as did fetal arterial PO2 (P < 0.05). Fetal arterial PCO2, pH and bicarbonate levels fell (P < 0.01). Glomerular filtration rate (GFR) rose (P < 0.01); there was a natriuresis (P < 0.01), chloriuresis (P < 0.01) and a kaliuresis (P < 0.05) but urine flow rate did not change. Lung liquid flow fell (P < 0.01). 5. It is concluded that in the fetus, long-term infusions of AII at a constant dose rate cause a progressive rise in arterial pressure. In addition, effects of AII on placental blood flow and on renal function develop. Thus, short-term infusions of AII cannot be used to predict the renal and cardiovascular effects of sustained high levels of this peptide in the fetus.(ABSTRACT TRUNCATED AT 400 WORDS)
This article has been cited by other articles:
![]() |
L. Shi, F. Hu, P. Morrissey, J. Yao, and Z. Xu Intravenous angiotensin induces brain c-fos expression and vasopressin release in the near-term ovine fetus Am J Physiol Endocrinol Metab, December 1, 2003; 285(6): E1216 - E1222. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. M. Moritz, K. Johnson, R. Douglas-Denton, E. M. Wintour, and M. Dodic Maternal Glucocorticoid Treatment Programs Alterations in the Renin-Angiotensin System of the Ovine Fetal Kidney Endocrinology, November 1, 2002; 143(11): 4455 - 4463. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. M. Moritz, D. J. Campbell, and E. M. Wintour Angiotensin-(1-7) in the ovine fetus Am J Physiol Regulatory Integrative Comp Physiol, February 1, 2001; 280(2): R404 - R409. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Moritz, I. Koukoulas, A. Albiston, and E. M. Wintour Angiotensin II infusion to the midgestation ovine fetus: effects on the fetal kidney Am J Physiol Regulatory Integrative Comp Physiol, October 1, 2000; 279(4): R1290 - R1297. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. J. Faber and D. F. Anderson Regulatory response of intramembranous absorption of amniotic fluid to infusion of exogenous fluid in sheep Am J Physiol Regulatory Integrative Comp Physiol, July 1, 1999; 277(1): R236 - R242. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. R. Poore, I. R. Young, B. J. Canny, and G. D. Thorburn Angiotensin II infusion in vivo does not modulate cortisol secretion in the late-gestation ovine fetus Am J Physiol Regulatory Integrative Comp Physiol, August 1, 1998; 275(2): R357 - R362. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |